Marcelo Fernandez-Vina, PhD, F (ACHI)
Professor
Department of Pathology Stanford University School of Medicine
Stanford, CA
Kazutoyo Osoegawa, PhD
Research Science & Technical Lead
Stanford Blood Center
Palo Alto, California
William Lane, MD, PhD, A(ACHI)
Director Tissue Typing Laboratory
Brigham and Women's Hospital
Boston, Massachusetts
Cathi Murphey, PhD, HCLD/CC(ABB), A(ACHI)
Director
SWID
Fair Oaks Ranch, Texas
Alberto Cardoso Martins Lima, PhD
Clinical Consulting Scientist
IGEN/AFIP and Federal University of Parana
Curitiba, Parana, Brazil
Renato De Marco, MSc (he/him/his)
co-director
Instituto Imunogenética, IGEN/AFIP
São Paulo, Sao Paulo, Brazil
Maria Bettinotti, PhD
Director, Immunogenetics Laboratory
Johns Hopkins University
Baltimore, MD
Arianne Mankey, CHS (ACHI)
HLA Clinical Lab Operations Manager
Stanford Blood Center Histocompatibility and Immunogenetics Laboratory
Palo Alto, CA
A new strategy for systematically classifying HLA alleles into associated antigens was recently approved by the W.H.O. Nomenclature Committee for Factors of the HLA System. The use of HLA Serotypes will facilitate virtual crossmatches and donor specific antibody assessments by offering a formal definition of antigens and informing the implementation of single antigen bead panels that encompass all clinically relevant variants.
To learn more please click here.
Speaker: Marcelo A. Fernandez-Vina, PhD, F (ACHI) – Department of Pathology Stanford University School of Medicine
Speaker: Kazutoyo Osoegawa, PhD – Stanford Blood Center
Speaker: William Lane, MD, PhD, A(ACHI) – Brigham and Women's Hospital
Speaker: Cathi Murphey, PhD, HCLD/CC(ABB), A(ACHI) – SWID
Speaker: Alberto Cardoso Martins Lima, PhD – IGEN/AFIP and Federal University of Parana